University of Colorado.
University of Colorado.
Behav Ther. 2020 Mar;51(2):334-349. doi: 10.1016/j.beth.2019.07.004. Epub 2019 Jul 23.
Recent work has drawn attention to the previously underrecognized role that irritability plays in childhood psychopathology. Despite increased recognition of the clinical importance of pediatric irritability as a transdiagnostic symptom dimension, there is a lack of evidence-based treatments for this population that simultaneously and equitably addresses both child and contextual (e.g., parental) factors implicated in the development and maintenance of associated emotional and behavioral difficulties. In the current pilot study, we adapted the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) for the treatment of pediatric irritability in a sample of 19 children (ages 8 to 12) with primary presenting concerns of irritability and/or disruptive behaviors. Results supported the feasibility and acceptability of this treatment and provided preliminary evidence that such an approach may yield improved outcomes for symptoms of pediatric irritability and disruptive behaviors. Implications of these findings for future research and clinical interventions for pediatric irritability are discussed.
最近的研究工作引起了人们对儿童精神病理学中以前被低估的易激惹作用的关注。尽管人们越来越认识到儿科易激惹作为一种跨诊断症状维度的临床重要性，但对于这一人群，缺乏同时针对儿童和（例如，父母）相关因素的循证治疗方法，这些因素与相关的情绪和行为困难的发展和维持有关。在当前的试点研究中，我们针对 19 名（年龄 8 至 12 岁）主要表现为易激惹和/或破坏性行为的儿童，对儿童情绪障碍的跨诊断统一治疗方案（UP-C）进行了改编，以治疗儿科易激惹。结果支持了这种治疗方法的可行性和可接受性，并提供了初步证据，表明这种方法可能会改善儿科易激惹和破坏性行为的症状。讨论了这些发现对未来儿科易激惹的研究和临床干预的意义。
